UnitedHealth (UNH) insider buying and selling
Every Table I transaction reported by directors and officers of S&P 500 companies on SEC Form 4 filings (2 business days to file): each row labeled with its official transaction code, nothing filtered out beforehand.
Open-market purchases (code P) are the rare signal, in green; sales (code S) are common and often pre-scheduled (10b5-1). Table II (derivatives) is not included: its prices are exercise prices, not market values. Guide: insider buying.
| Date | Ticker | Insider | Role | Shares | Price | Amount | % of stake | Type / filing |
|---|
Download these transactions as CSV No account, no sign-up. The data is public: it comes from SEC Form 4 filings.
UnitedHealth Group Incorporated (UNH) insider buying and selling: no purchases, 4 sales
150 Form 4 Table I transactions filed with the SEC by UnitedHealth Group Incorporated insiders between 2025-09-04 and 2026-10-05 (15-month history): 0 open-market purchases and 4 sales, plus 146 transactions under other Form 4 codes, broken down one by one below. The largest open-market trade is a sale of $456k by Conway Patrick Hugh on 2026-08-21.
UnitedHealth insider buying and selling over the last 12 months
Between Oct 21, 2025 and Oct 20, 2026, UnitedHealth insiders filed 3 sales worth $945k on the open market, and no purchases.
The biggest seller was Conway Patrick Hugh (Chief Executive Officer, Optum): $945k in 3 sales, the only seller.
The largest trade of the period was a sale of $456k on Aug 21, 2026, by Conway Patrick Hugh (Chief Executive Officer, Optum). Form 4 on sec.gov (0000731766-26-000201).
None of the 3 sales carries the 10b5-1 plan flag on the Form 4 (sales scheduled months ahead).
The last three months show 2 sales, against 1 in the three before. The latest sale from Aug 21, 2026.
Against its sector (Healthcare, 59 companies with an insider page on this site), over the same dates the median is 9 sales and 0 purchases on the open market. UnitedHealth has more sales than 12 of the other 58, ranks 49 of 59 by net dollars sold, and 19 of the 59 have at least one purchase.
The 20 most important trades
With no open-market purchases, the table starts with UNH's sales, largest first. The full history is in the tool above, already searched.
See all 150 UNH trades in the full history →
| Trade date | Filed | Insider | Role | Amount | Code | Filing |
|---|---|---|---|---|---|---|
| 2026-08-21 | 2026-08-25 | Conway Patrick Hugh | Chief Executive Officer, Optum | $456k | S — Open-market sale | SEC |
| 2026-04-23 | 2026-04-27 | Conway Patrick Hugh | Chief Executive Officer, Optum | $284k | S — Open-market sale | SEC |
| 2026-08-05 | 2026-08-07 | Conway Patrick Hugh | Chief Executive Officer, Optum | $205k | S — Open-market sale | SEC |
| 2025-09-11 | 2025-09-15 | Baker Charles D. | Director | $10k | S — Open-market sale Indirect holding, through: By Trust Form 4 footnoteF1 On August 1, 2025, the reporting person acquired indirect beneficial ownership of 27 UNH shares by means of an inheritance. This acquisition of securities was exempt from reporting pursuant to Rules 16a-3 and 16b-5 under the Securities Exchange Act of 1934, as amended. | SEC |
| 2026-02-23 | 2026-02-25 | Deveydt Wayne S | Chief Financial Officer | $2.5M | A — Grant or awardForm 4 footnoteF1 The restricted stock units vest at a rate of 25% annually on February 23 from the years 2027 through 2030. | SEC |
| 2026-09-02 | 2026-09-04 | Deveydt Wayne S | Chief Financial Officer | $483k | F — Tax withholding (shares surrendered for taxes) | SEC |
| 2026-06-05 | 2026-06-09 | Conway Patrick Hugh | Chief Executive Officer, Optum | $274k | F — Tax withholding (shares surrendered for taxes) | SEC |
| 2026-02-20 | 2026-02-24 | Conway Patrick Hugh | Chief Executive Officer, Optum | $146k | F — Tax withholding (shares surrendered for taxes) | SEC |
| 2026-02-20 | 2026-02-24 | Noel Timothy John | Chief Executive Officer, UHC | $135k | F — Tax withholding (shares surrendered for taxes) | SEC |
| 2026-02-20 | 2026-02-24 | Zaetta Christopher R | EVP & Chief Legal Officer | $129k | F — Tax withholding (shares surrendered for taxes) | SEC |
| 2026-02-20 | 2026-02-24 | Roos Thomas E | Chief Accounting Officer | $95k | F — Tax withholding (shares surrendered for taxes) | SEC |
| 2026-02-13 | 2026-02-17 | Roos Thomas E | Chief Accounting Officer | $94k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. | SEC |
| 2026-08-11 | 2026-08-13 | Stankiewicz Dennis Andrew | Chief Accounting Officer | $94k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. | SEC |
| 2026-02-13 | 2026-02-17 | Conway Patrick Hugh | Chief Executive Officer, Optum | $87k | F — Tax withholding (shares surrendered for taxes) | SEC |
| 2026-02-20 | 2026-02-24 | Mcsweeney Erin | EVP & Chief People Officer | $85k | F — Tax withholding (shares surrendered for taxes) | SEC |
| 2026-06-02 | 2026-06-04 | Conway Patrick Hugh | Chief Executive Officer, Optum | $77k | F — Tax withholding (shares surrendered for taxes) | SEC |
| 2026-02-13 | 2026-02-17 | Zaetta Christopher R | EVP & Chief Legal Officer | $62k | F — Tax withholding (shares surrendered for taxes) | SEC |
| 2026-02-23 | 2026-02-25 | Conway Patrick Hugh | Chief Executive Officer, Optum | $51k | F — Tax withholding (shares surrendered for taxes) | SEC |
| 2026-06-03 | 2026-06-04 | Zaetta Christopher R | EVP & Chief Legal Officer | $51k | F — Tax withholding (shares surrendered for taxes) | SEC |
| 2026-02-13 | 2026-02-17 | Mcsweeney Erin | EVP & Chief People Officer | $45k | F — Tax withholding (shares surrendered for taxes) | SEC |
The period balance: money in, money out
In the Form 4 filings submitted between Sep 4, 2025 and Oct 5, 2026 there is not one open-market purchase of UnitedHealth Group Incorporated: 4 sales worth $955k and zero dollars bought.
Only codes P and S count, where an insider puts in or takes out their own money. A selling balance like UnitedHealth Group Incorporated's is the norm in the S&P 500, where much of the pay comes as stock. It is not a recommendation to buy or sell: it is what was filed.
Every transaction, code by code
| Code | What it means | Trades | Reported amount |
|---|---|---|---|
| A | Grant or award | 125 | $2.5M |
| F | Tax withholding (shares surrendered for taxes) | 20 | $2.1M |
| S | Open-market sale | 4 | $955k |
| G | Gift | 1 | $0 |
| Total | Everything filed in the period | 150 | $5.5M |
125 of the 150 rows carry no usable amount on the Form 4: they count as trades and add $0. The code labels come from the SEC index.
Who has traded
Over the 15 months of history, 17 distinct people or entities have filed UnitedHealth Group Incorporated transactions: none bought on the open market and 2 sold. Counted by CIK, the fixed number the SEC gives each filer, and not by name, which each filer types their own way.
| Filer | Role | Transactions | Bought (count) | Sold (count) | Last filed |
|---|---|---|---|---|---|
| Conway Patrick Hugh | Chief Executive Officer, Optum | 14 | — | $945k (3) | 2026-09-24 |
| Baker Charles D. | Director | 11 | — | $10k (1) | 2026-10-05 |
| Flynn Timothy Patrick | Director | 10 | — | — | 2026-10-05 |
| Garcia Paul R | Director | 10 | — | — | 2026-10-05 |
| Gil Kristen | Director | 10 | — | — | 2026-10-05 |
| Mcnabb Frederick William Iii | Director | 10 | — | — | 2026-10-05 |
| Montgomery Rice Valerie Md | Director | 10 | — | — | 2026-10-05 |
| Noseworthy John H | Director | 10 | — | — | 2026-10-05 |
Shown here are the 8 who moved the most money, out of 17. The rest are in the full history, one link above. The name links to all their trades, in any company. "Transactions" counts any code; the money, open market only. Role: from their latest filing.
Month by month
By the month the trade was executed, not the month it was filed; months with no trades show zero. The busiest month was Aug 2026: 0 purchases and 2 sales, worth $661k. 12 of the 15 months have none.
| Month | Purchases | Amount | Sales | Amount |
|---|---|---|---|---|
| Aug 2025 | 0 | $0 | 0 | $0 |
| Sep 2025 | 0 | $0 | 1 | $10k |
| Oct 2025 | 0 | $0 | 0 | $0 |
| Nov 2025 | 0 | $0 | 0 | $0 |
| Dec 2025 | 0 | $0 | 0 | $0 |
| Jan 2026 | 0 | $0 | 0 | $0 |
| Feb 2026 | 0 | $0 | 0 | $0 |
| Mar 2026 | 0 | $0 | 0 | $0 |
| Apr 2026 | 0 | $0 | 1 | $284k |
| May 2026 | 0 | $0 | 0 | $0 |
| Jun 2026 | 0 | $0 | 0 | $0 |
| Jul 2026 | 0 | $0 | 0 | $0 |
| Aug 2026 | 0 | $0 | 2 | $661k |
| Sep 2026 | 0 | $0 | 0 | $0 |
| Oct 2026 | 0 | $0 | 0 | $0 |
The last month may be partial: a Form 4 is filed up to two business days later. The table does not say whether the pattern is good or bad; it says when it happened.
UnitedHealth Group Incorporated (UNH) analysis page →
Other Healthcare companies with insider trades
All 500 are listed in the section index →
Which insiders are buying their own company stock →
How to read this data
None of the 4 sales in the table is flagged as scheduled (10b5-1 plan), the kind signed months ahead and executed automatically. UnitedHealth has no open-market purchase (code P) in the history, the most common case in the S&P 500: insiders are already paid in stock. The latest filing is from Oct 5, 2026, and a Form 4 arrives up to two business days after the trade.
4 of the 20 rows in the table carry footnotes from the Form 4 itself, folded into the code column and copied verbatim; a row with no footnote means the filing has none.
Guide: Insider buying · all guides
What is behind these trades
The concepts on this page, explained from scratch in the Academy. Free, no account.
- What the efficiency hypothesis says and what it does NOT sayIf an insider's purchase is public and anyone can read it, is there any information left in it? That is the exact question that brings people here.
- Who really moves the market: the types of investorWho sits on the other side of each order, and where a company's own insiders fit among them.
- Supply, demand and price: why it rises and falls constantlyHow a piece of news ends up inside the price, and why the reaction to a filed sale is rarely the one you would expect.
Source: SEC EDGAR Form 4. This is a list of public facts, not financial advice or a recommendation to buy or sell.